Servier Affaires Médicales
Clinical trials sponsored by Servier Affaires Médicales, explained in plain language.
-
New combo pill and injection aims to control leukemia in frail patients
Disease control Recruiting nowThis study tests a combination of two drugs—ivosidenib (a daily pill) and azacitidine (an injection or infusion)—in adults newly diagnosed with a type of acute myeloid leukemia (AML) that has an IDH1 gene mutation. The participants are not healthy enough for standard intensive ch…
Phase: PHASE3 • Sponsor: Servier Affaires Médicales • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for rare bile duct cancer: targeted pill shows promise in Late-Stage trial
Disease control Recruiting nowThis study tests a daily pill called ivosidenib in 220 adults with advanced bile duct cancer that has a specific IDH1 gene mutation and has not responded to prior treatment. The goal is to confirm the drug's safety and effectiveness. Participants take the tablet once daily in 28-…
Phase: PHASE3 • Sponsor: Servier Affaires Médicales • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC